Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy.
暂无分享,去创建一个
[1] Philip M. Kim,et al. Conjugating Ligands to an Equilibrated Nanoparticle Protein Corona Enables Cell Targeting in Serum , 2022, Chemistry of Materials.
[2] M. Pittet,et al. Clinical relevance of tumour-associated macrophages , 2022, Nature Reviews Clinical Oncology.
[3] Zheng Gu,et al. Leveraging Macrophages for Cancer Theranostics. , 2022, Advanced drug delivery reviews.
[4] Ziyang Cao,et al. A siRNA-Assisted Assembly Strategy to Simultaneously Suppress "Self" and Upregulate "Eat-Me" Signals for Nanoenabled Chemo-Immunotherapy. , 2021, ACS nano.
[5] Yong Gan,et al. Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages. , 2021, Nano letters.
[6] Juan Li,et al. Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure , 2021 .
[7] Christine E. Brown,et al. Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy , 2021, Frontiers in Immunology.
[8] M. Gelinsky,et al. Tailoring Materials for Modulation of Macrophage Fate , 2021, Advanced materials.
[9] Xiangrui Liu,et al. Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention , 2020, Advanced functional materials.
[10] X. Fang,et al. Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy. , 2020, Biomaterials.
[11] K. Leong,et al. Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy. , 2020, Small.
[12] Xiaoyuan Chen,et al. Engineering Macrophages for Cancer Immunotherapy and Drug Delivery , 2020, Advanced materials.
[13] Wenbin Lin,et al. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy. , 2020, Journal of the American Chemical Society.
[14] Yong Wang,et al. M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects , 2020, ACS central science.
[15] Xuesi Chen,et al. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers , 2020, Science Advances.
[16] Aaron J. Johnson,et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity , 2020, Nature Communications.
[17] Hai‐Yan Xie,et al. Responsive exosome nano-bioconjugates for synergistic cancer therapy. , 2019, Angewandte Chemie.
[18] R. Medzhitov,et al. Harnessing innate immunity in cancer therapy , 2019, Nature.
[19] Betty Y. S. Kim,et al. Phagocytosis checkpoints as new targets for cancer immunotherapy , 2019, Nature Reviews Cancer.
[20] H. Daldrup-Link,et al. Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell ‘don't eat me’ signals off and ‘eat me’ signals on , 2019, Molecular oncology.
[21] Xiaoyuan Chen,et al. In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy. , 2019, ACS nano.
[22] Brian Ruffell,et al. Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.
[23] S. Trefely,et al. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated ‘don’t eat me signal’. , 2018, Nature Immunology.
[24] I. Weissman,et al. Programmed cell removal by calreticulin in tissue homeostasis and cancer , 2018, Nature Communications.
[25] Ding Ding,et al. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.
[26] yang-xin fu,et al. Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion. , 2018, Cell reports.
[27] Yiyun Cheng,et al. The fluorination effect of fluoroamphiphiles in cytosolic protein delivery , 2018, Nature Communications.
[28] D. Waxman,et al. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy. , 2018, Cancer letters.
[29] P. Tacnet-Delorme,et al. Calreticulin Release at an Early Stage of Death Modulates the Clearance by Macrophages of Apoptotic Cells , 2017, Front. Immunol..
[30] N. Khashab,et al. Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles , 2017, Advanced materials.
[31] L. Zitvogel,et al. Immunogenic cell death in cancer and infectious disease , 2016, Nature Reviews Immunology.
[32] Abhishek D. Garg,et al. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma , 2016, Science Translational Medicine.
[33] yang-xin fu,et al. CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors , 2015, Nature Medicine.
[34] S. Martin,et al. Danger signalling during cancer cell death: origins, plasticity and regulation , 2013, Cell Death and Differentiation.
[35] Jens-Peter Volkmer,et al. Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies , 2013, Science.
[36] Jens-Peter Volkmer,et al. Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response , 2013, Proceedings of the National Academy of Sciences.
[37] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[38] Jens-Peter Volkmer,et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors , 2012, Proceedings of the National Academy of Sciences.
[39] Ash A. Alizadeh,et al. Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 , 2010, Science Translational Medicine.
[40] I. Weissman,et al. CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis , 2009, Cell.
[41] Ash A. Alizadeh,et al. CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells , 2009, Cell.
[42] T. Matozaki,et al. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. , 2009, Trends in cell biology.
[43] L. Zitvogel,et al. Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.
[44] W. Janssen,et al. Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte , 2005, Cell.
[45] J. Nuutila,et al. Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.